---
schema_version: "secwatch.filing_event.v1"
accession: "0001100682-25-000032"
form_type: "8-K"
ticker: "CRL"
cik: "0001100682"
company_name: "CHARLES RIVER LABORATORIES INTERNATIONAL, INC."
filed_at: "2025-08-06T23:59:59+00:00"
generated_at: "2026-05-17T18:53:12.819867+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Charles River Q2 non-GAAP EPS $3.12 beats; raises 2025 guidance; DOJ closes NHP probe

## Summary
- Q2 revenue $1.032B (+0.6% reported; organic -0.5%); GAAP EPS $1.06, non-GAAP EPS $3.12 up 11.4% YoY.
- Non-GAAP operating margin improved to 22.1% from 21.3%; DSA non-GAAP margin slightly up to 27.4%.
- Raises FY2025 non-GAAP EPS guidance to $9.90-$10.30 (prior $9.30-$9.80); revenue growth (2.5%)-(0.5%).
- DOJ closes grand jury and civil investigations into NHP supply chain; no action taken.
- Segment organic growth: RMS +2.3%, DSA -2.4%, Manufacturing +2.9%; cost savings from restructuring.

## SEC filing metadata
- accession: 0001100682-25-000032
- form_type: 8-K
- ticker: CRL
- cik: 0001100682
- company_name: CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- filed_at: 2025-08-06T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1100682/000110068225000032/0001100682-25-000032-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1100682/000110068225000032/crl-20250806.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001100682-25-000032
- JSON: https://secwatch.observer/filing/0001100682-25-000032.json
- Plain text: https://secwatch.observer/filing/0001100682-25-000032.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.